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Parkinson’s disease (PD) is a common age-related neurodegenerative disorder thought to result from the integrated eﬀects of ge-
netic background and exposure to neuronal toxins. Certain individual nuclear-encoded mitochondrial complex I gene polymor-
phisms were found to be associated with ∼ 2-fold risk variation in an Australian case-control sample. We further characterized
this sample of 306 cases and 321 controls to determine the mutual information contained in the 22SNPs and, additionally, level
of pesticide exposure: ﬁve distinct risk sets were identiﬁed using grade-of-membership analysis. Of these, one was robust to pesti-
cide exposure (I), three were vulnerable (II, III, IV), and another (V) denoted low risk for unexposed persons. Risk for individual
subjects varied > 16-fold according to level of membership in the vulnerable groups. We conclude that inherited variation in mi-
tochondrial complex I genes and pesticide exposure together modulate risk for PD.
Copyright © 2006 E. H. Corder and G. D. Mellick. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
INTRODUCTION
Parkinson’s disease (PD) is a common age-related neurode-
generative disorder thought to result from the integrated ef-
fects of genetic background and exposure to neuronal tox-
ins (eg, MPTP, rotenone and other insecticides). Rarely, it is
caused by mendelian mutations (α-synuclein, DJ-1, PINK1,
and LRRK2). Tremor, rigidity, slowness of movement and
postural instability are the predominant symptoms due to
the selective loss of pigmented dopamine-producing neu-
rons in the substantia nigra pars compacta region of the
brain. Whether familial, age-related, or consequent to neu-
ronal toxin exposure, impaired mitochondrial complex I
(NADH:ubiquinoneoxidoreductase; EC 1.6.5.3) is found [1–
17]. Mitochondrial complex I consists of at least 46 subunits,
sevenencodedinthemitochondrialgenomeandtheremain-
der, at least 39, encoded in the nucleus.
One testable hypothesis is that PD risk is modulated by
inherited sequence variation in complex I genes. Mellick et
al [1] addressed this possibility: they screened for single nu-
cleotide polymorphisms (SNPs) in nuclear encoded complex
I genes. A total of 22SNPs (16 genes) polymorphic among
Australians were investigated (306 PD patients; 321 control
subjects). Statistically signiﬁcant associations, and ∼ 2-fold
variation in risk, were observed for NDUF genes A1, A10,
A6, and S4, when taken individually. None of these associa-
tions would have survived correction for multiple compar-
isons. Although information on pesticide exposure, sex, and
age at onset was available, it was not used in the association
analysis due to the limited sample size and the larger number
of multiple comparisons that would have been generated.
We extend this work by jointly investigating the 22SNP
genotypes found for these 306PD patients and 321 con-
trol subjects, avoiding multiple comparisons, and consider-
ing level of pesticide exposure and age at onset. The goals
were to identify combinations of alleles robust to pesticide
exposure, others that are especially vulnerable, and to quan-
tify risk for individuals. This was accomplished using grade-
of-membership analysis or GoM.
Using GoM, two sets of parameters are simultaneously
estimated by maximum likelihood (see “Methods”). One set
represents a speciﬁed number of extreme pure type groups.
Here, each of the ﬁve groups has distinct frequencies for the
SNP genotypes, level of toxin exposure, and PD status ac-
cording to age. The other set of parameters represents the
degree of similarity of each subject to the groups. These2 Journal of Biomedicine and Biotechnology
graded membership scores range from zero, that is, denoting
no resemblance to the group, to one, that is, the individual
matches the group exactly, and sum to one for each person.
The scores can be input into logistic models to quantify dis-
ease risk and produce 95% CI. This approach has identiﬁed
highly predictive suﬃcient genetic risk sets for Alzheimer’s
disease [18] and multilocus genotypes speciﬁc to breast can-
cer and ﬁbroadenoma [19].
Fivemodel-basedgroupsrelevanttoPDstatuswereiden-
tiﬁed. Of these, one set of complex I polymorphisms was ro-
bust to pesticide exposure (I), three sets were vulnerable (II,
III,IV),andanother(V)denotedlowriskforunexposedper-
sons. Risk for individuals varied > 16-fold according to level
of membership in the vulnerable groups. We conclude that
inherited variation in mitochondrial complex I genes and
pesticide exposure together modulate risk for PD.
METHODS
The speciﬁc details of the case-control sample and the geno-
typing methods used have been reported previously [1].
Studysubjects
Onset ranged over six decades of age among the 306 case
subjects (decade of age: %): 30–39: 3%, 40–49: 12%, 50–
59: 31%, 60–69: 36%, 70–79: 16%, 80+ : 2%. The cases did
not have symptoms of other neurological conditions, for ex-
ample, change in cognition suggestive of Alzheimer’s disease
onset. The 321 control subjects did not have any symptom
of parkinsonism (decade of age: %): 30–39: 1%, 40–49: 6%,
50–59: 22%, 60–69: 36%; 70–79: 31%, 80+ : 4%.
Environmentalexposures
A structured questionnaire was used to probe for exposures
to environmental toxins including insecticides, herbicides,
fungicides, solvents, heavy metals [20]. However, this study
limited exposure assessment to self-reported exposures to
pesticides (ie, insecticides, herbicides, and fungicides). Re-
sponses were coded as 0 = no exposure, 1 = limited expo-
sure, and 2 = regular exposure at least weekly for six months.
Pesticide exposure was more common among men and cases
(men: 63% vs 55%; women: 46% vs 39%), especially regular
exposure (men: 20% vs 9%; women: 5% vs 3%).
Geneticdeterminations
SNPs in nuclear genes that encode mitochondrial complex I
proteins were identiﬁed from the HGVbase as of July 2001
[1]. The 22 of 70 identiﬁed SNPs polymorphic among 16
randomly selected healthy Australian subjects are investi-
gated (Table 1). SNP determinations were made using the
DASH method [21, 22]. The major allele at each locus was
coded as “a” and the minor allele “b” yielding genotypes
aa, ab,a n dbb. Multilocus genotypes were coded, for exam-
ple, aa:ab, for genes having more than one SNP. Infrequent
(0.018) missing values were ignored in the data analysis.
Table 1: The genes and SNPs investigated.
Number Gene SNP (HGV base ID)
1 DLST SNP000002340 (A/G)
2 NDUFA1 SNP000005157 (G/C)
3 NDUFA1 SNP000008196 (T/C)
4 NDUFA1 SNP000008197 (T/G)
5 NDUFA10 SNP000015174 (G/A)
6 NDUFA10 SNP000020002 (A/G)
7 NDUFA6 SNP000005146 (C/T)
8 NDUFA7 SNP000005158 (C/T)
9 NDUFA8 SNP000005147 (A/G)
10 NDUFA8 SNP000008968 (G/A)
11 NDUFB4 SNP000019034 (C/T)
12 NDUFB7 SNP000005144 (C/G)
13 NDUFB8 SNP000005127 (C/A)
14 NDUFB9 SNP000005142 (C/T)
15 NDUFS1 SNP000005158 (G/T)
16 NDUFS1 SNP000005159 (A/G)
17 NDUFS2 SNP000018866 (T/A)
18 NDUFS4 SNP000005133 (A/G)
19 NDUFS4 SNP000005178 (G/A)
20 NDUFS7 SNP000005156 (T/C)
21 NDUFS8 SNP000005155 (C/T)
22 NDUFV2 SNP000000182 (C/T)
Thedataanalyticapproach
Detailed clinical genetic proﬁles were identiﬁed using grade-
of-membership analysis or GoM [23–25]. Case subjects were
considered according to age (< 60, 60–69, 70+) and envi-
ronmental exposure (0,1,2); control subjects were coded ac-
cording to exposure regardless of age, that is, 12 categories
total.
GoM can be described after ﬁrst identifying four indices.
One is the number of subjects I (i = 1,2,...,I). Here, I =
627 subjects were identiﬁed. The second index is the number
of variables J (j = 1,2,...,J). There are J = 17 variables.
Our third index is Lj: the set of response levels for the Jth
variable. This leads to the deﬁnition of the basic GoM model
where the probability that the ith subject has the Ljth level of
theJthvariableisdeﬁnedbyabinaryvariable(ie, yijl = 0,1).
The model with these deﬁnitions is
Prob
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
=

k
gikλkjl,( 1 )
where the gik are convexly constrained scores (ie, 0.0
￿ gik
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￿ Lj responses
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The parameters gik and λkjlare estimated simultaneously
using the likelihood function (in its most basic form).
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In the likelihood yijl is 1.0 if the Ljth level is present and
0.0ifitisnotpresent.Decadeofageprovidedstartingvalues.
Information on sex was available to further characterize
the groups. One option in the likelihood is to separate calcu-
lations for “internal” (here, clinical and genetic) and “exter-
nal” (here, sex) variables. For internal variables, maximum
likelihood estimations (MLE) of gik and λkjl are generated
and the information in internal variables is used to deﬁne
the K groups. For external variables the likelihood is evalu-
ated (and MLE of λkjl; generated) but the information is not
used to redeﬁne the K groups, that is, the likelihood calcu-
lations for likelihood equations involving the gik are disabled
for external variables so that the gik, and the deﬁnition of the
K groups, is not changed.
Next, three age-speciﬁc logistic models (< age 60, 60–69,
70+) were constructed to estimate the risk for PD accord-
ing to membership in the vulnerable groups II, III, and IV.
For this use, the graded membership scores were categorized
from 1 (< 0.20 membership) to 5 (> 0.80 membership) rep-
resenting 0.20 increments.
RESULTS
Five GoM groups represent the data, displayed in Table 2.
Group I was robust to toxin exposure. Groups II, III, and
IV were vulnerable. Group V had limited toxin exposure and
wasatlowrisk.EachgrouphadadistinctivesetofSNPgeno-
types for nuclear genes that encode mitochondrial complex I
subunits.
Robusttopesticideexposure(I)
Low risk for PD despite limited toxin exposure carried a dis-
tinctive genetic signature of infrequent genotypes: X-linked
A1 aa:ab:ab or bb:aa:aa, A6 bb, A8 bb:a-, A10 ab:aa, B4 ab,
B8 ab or bb B9 ab, S1 ab:aa,a n dS4 bb:ab. The group con-
sisted predominantly of females (84% chance). There was
some chance of being aﬀected at ages 70 or older after reg-
ular exposure to toxins despite this protective signature.
Earlyonset,regularexposure(II)
Group II was aﬀected before age 60 and vulnerable to regular
pesticide exposure. Its genetic signature consisted of A6 aa,
A8 ab:ab, A10 aa:bb, S1 bb:a, the common S2 ab genotype
found also for group I, and DLST bb.
EarlyonsetPD,limitedexposure(III)
Group III also had high risk for PD with onset before age
60(86%), at limited pesticide exposure (43%). This vulner-
ability was associated with A6 ab, B7 bb,a n dDLST aa.H o -
mozygous V2 bb was found (22%) for this group only.
LateonsetPD,limitedexposure(IV)
GroupIVwasatriskforPD(63%)atages60to69,atlimited
pesticide exposure (70%). It had genetic signature A8 aa:aa,
B7 ab, S1 bb:bb, S2 bb, S4 bb:aa,a n dS8 bb.
Lowrisk,noexposure(V)
GroupVrepresentslowriskforPDwhennotexposedtopes-
ticides. Two SNP genotypes stand out as determinants: V2
ab (QRF = 1.47—the highest genetic inﬂuence score) and
S4 aa:aa (QRF = 1.25). QRF stands for “question relevance
score” denoting the relative importance of the variable in de-
termining the group.
Informativevariables
No one genetic variable dominated. An information statis-
tic H, related to Shannon’s information statistic (Bell Lab-
oratories) was estimated for each variable: values close to
zero indicate that the variable was not useful. Three of four
SNPs deemed statistically signiﬁcant in chi-square analyses
(A6:H = 0.92, A10 : H = 0.68, S4:H = 1.13) [1]
were identiﬁed as being highly informative. The fourth, A1,
had limited heterozygosity and low H score (0.19). Nonethe-
less, 8196b + 8197b distinguished robust group I from the
other groups. Additional loci were highly informative: B7
bb was associated with risk (III), aa with protection (I, V)
(H = 1.07); A8 5147 bb was protective (I); risk was asso-
ciated with 8968 ab for persons exposed to pesticides (II)
(H = 0.84), among others as shown in Table 1.
RISK FOR PARKINSON’S DISEASE
Figure 1 shows the membership distributions of case and
c o n t r o ls u b j e c t si ne a c ha g eg r o u p( < age 60, 60 to 69,
70+). Few subjects exactly matched the respective groups (N
= 0,1,1,3,1). Most divided membership, for example, had
SNP genotypes found for several of the extreme pure type
groups shown in Table 1. Relatively few subjects had mem-
bership scores of 0.60 or higher (0.60–0.79: green; 0.80–1.00:
gray).Nonetheless,severaltrendswereapparent:casesoccur-
r i n gb e f o r ea g e6 0t e n d e dt or e s e m b l eg r o u p sI Ia n dI I Im o r e
than the control subjects. Cases at ages 60 to 69 resembled
group IV. Cases at age 70 and older did not over-represent
II, III, and IV. Instead, both cases and controls most strongly
resembled group V, that is, there may be a survival advantage
for this set of polymorphisms. Note the consonance of mem-
bership distributions for control subjects in each age group.
The odds of PD, for subjects in each age group, were pre-
dicted by membership in groups II, III, and IV in logistic
models(Figure 2).EarlyonsetPDwassigniﬁcantlypredicted
bygroupsII“earlyonset,regularexposure”andIII“earlyon-
set, limited exposure” (OR (95% CI): 2.7( 1 .8t o4 .0) and
4.0( 2 .5t o6 .5)), respectively. Note that the conﬁdence lim-
its do not include the neutral reference value of one, which
would denote no risk. Hence, even limited resemblance of
subjects to either group, that is, membership score 0.20–0.39
versus < 0.20, carries statistically signiﬁcantly increased risk.4 Journal of Biomedicine and Biotechnology
Table 2: Probabilities for each variable outcome found for GoM groups I to V. Group I: “robust to pesticide exposure,” group II “early onset
PD, regular exposure,” groupIII:“early onset PD, limited exposure,” groupIV“late onset PD, limited exposure,” groupV“low risk, no exposure.”
Variable &outcome Sample freq. I II III IV V H-value
Disease status & pesticide exposure 1.41
PD, < age 60
None 8.77 — — 57 — —
Limited 10.21 — 62 29 — —
Regular 3.51 — 38 — — —
PD, ages 60–69
None 8.61 — — — 31 —
Limited 7.02 — — — 25 —
Regular 2.0 7——— 7 —
PD, ages 70+
None 4.6 3————13
Limited 3.0 3———— 8
Regular 0.96 8 — — — —
Control
None 28.0 7 ————79
Limited 20.26 85 — — 37 —
Regular 2.87 7 — 14 — —
A1:5157-8196-8197
aa:aa:aa 90.16 57 100 100 90 94 0.19
aa:ab:ab 5.41 3.7————
aa:bb:bb 2.46 — — — 10 —
ab:aa:aa 1.1 5 ———— 6
bb:aa:aa 0.82 6 — — — —
A6:5146
aa 46.62 — 100 ——8 2 0 .92
ab 42.93 — — 100 84 —
bb 10.45 100 — — 16 18
A7:5148
aa 68.76 100 100 32 100 — 0.57
ab 27.21 — — 49 — 100
bb 4.03 — — 20 — —
A8:5147-8968
aa:aa 36.1 6 ———88 55 0.84
ab:aa 34.36 42 57 100 — —
ab:ab 14.50 — 43 — — 32
bb:aa 7.17 46 — — — —
bb:ab 6.35 12 — — 6 13
bb:bb 1.4 7 ——— 5 —
A10:15174-20002
aa:aa 21.64 — 33 31 15 29 0.68
aa:ab 30.66 23 —5 25 63 4
aa:bb 17.21 — 67 ———
ab:aa 16.18 77 ————
ab:ab 14.31 — — 17 29 37
B4:19034
aa 79.39 — 100 100 97 100 0.43
ab 19.97 100 ————
bb 0.6 4 ——— 3 —
B7:5144
aa 25.69 100 — — — 100 1.07
ab 50.57 — 100 — 100 —
bb 23.74 — — 100 — —
B8:5127
aa 62.86 — 100 100 45 65 0.39
ab 32.15 71 — — 55 35
bb 4.98 29 ————
B9:5142 aa 92.08 50 100 100 100 100 0.16
ab 7.92 50 — — — —E. H. Corder and G. D. Mellick 5
Table 2: Continued.
S1:5158-5159
aa:aa 30.54 13 35 — 58 31 0.65
ab:aa 12.48 48 — 32 — —
ab:ab 37.60 40 25 68 — 69
bb:aa 1.6 4 —7— — —
bb:ab 7.7 2 —3 3———
bb:bb 10.02 — — — 42 —
S2:18866
aa 44.64 — — 100 53 100 0.81
ab 45.62 100 100 ———
bb 9.74 — — — 47 —
S4:5133-5178
aa:aa 25.2 8 ————97 1.13
ab:aa 26.09 — 50 68 — —
ab:ab 25.7 7 —3 83 25 7—
bb:aa 7.62 — — — 43 —
bb:ab 11.67 100 — — — —
bb:bb 3.5 7 —1 2—— 3
S7:5156
aa 28.6 2 —4 86 02 9— 0 .40
ab 55.79 100 52 9 28 100
bb 15.59 — — 31 42 —
S8:5155
aa 69.03 100 83 66 25 85 0.21
ab 25.8 4 —1 73 45 21 5
bb 5.13 — — — 22 —
V2:182
aa 66.07 100 100 78 100 — 0.60
ab 30.6 8 ———— 100
bb 3.25 — — 22 — —
DLST:2340
aa 24.23 — — 86 —— 0 .72
ab 57.84 100 18 14 100 100
bb 17.9 3 —8 2———
Note: inﬂuential genotypes in determining the group are indicated in bold. The question relevance factor (QRF) score for that variable and group was
> 1.20.
Each 0.20 increment multiplies risk: successive increments in
group II membership carry risks of 2.67, 7.13, and 29.0. Suc-
cessive increments in group III membership carry risks of 4,
16,and64.Higherlevelsofriskarepredictedby,forexample,
0.5 membership in each of groups II and III.
Onset at ages 60 to 69 was signiﬁcantly predicted by
groups II “early onset, regular exposure” and IV “late onset,
limited exposure” (OR (95% CI): 1.6( 1 .1t o2 .3) and 2.63
(1.8t o3 .8)). Successive increments in group II membership
carryrisksof1.6,2.6,and4.0.Successiveincrementsingroup
IV membership carry risks of 2.63, 6.9, and 18.2. Higher lev-
els of risk are predicted by, for example, 0.5 membership in
each of groups II and IV.
The model was not predictive at ages 70 and older, that
is, the global hypothesis that the parameter values were zero
could not be rejected (P = .15).
DISCUSSION
The object of this study is the mutual information con-
tained in multiple SNPs located in nuclear genes that encode
mitochondrial complex I subunits, level of toxin exposure,
andParkinson’sdiseasestatusaccordingtoage.Apriorinves-
tigationofindividualSNPsinthestudysample[1]foundr el-
ative risks of about two for PD associated with certain SNPs
locatedinNDUF genesA1,A10,A6,andS4.Thismoreinclu-
sive analysis replicated these ﬁndings and yielded better esti-
mates of risk in relation to the available information. Specif-
ically, ﬁve model-based groups were identiﬁed that repre-
sented robustness to pesticide exposure (I), vulnerability to
regular (II) and limited exposure (III, IV) and low risk in
theabsenceofexposure(V).Therobustgroupconsistedpre-
dominantlyoffemalesandcarriedasetoflessfrequentalleles
including one on the X chromosome. The vulnerable groups
diﬀered according to age at onset (< age 60 for II and III; age
60 to 69 for group IV) and level of toxin exposure (limited
or regular for II, none or limited for groups III and IV). Even
the low risk groups I and V had some level of risk for PD
at ages 70 and older. Thus the mutual information investi-
gated using GoM was more informative in terms of age, sex,
and toxin exposure compared to straightforward association
analysis.6 Journal of Biomedicine and Biotechnology
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(c) Subjects age 70 or older: 54 PD cases, 114 controls
Figure 1: Individuals have assigned membership scores in the groups. These continuous scores ranging from 0 to 1 have been categorized
as < 0.20, 0.20–0.39, 0.40–0.59, 0.60–0.79, and 0.80 to 1.00. Control subjects in each age group have similar frequency distributions of
membership. Case subjects < age 60 over-represent membership in groups II and III, group IV at ages 60 to 69. Cases at age 70 and older
over-represent the groups I and V.
This approach, avoiding multiple comparisons which
wouldhavedecimatedeachoftheindividualassociations[1],
wasabletoestimateriskforindividualsaccordingtothelevel
of membership in the vulnerable groups. At ages < 60, sta-
tistically signiﬁcant 3-fold and 4-fold elevation in risk was
found for persons who had limited (0.20–0.39) resemblance
to groups II and III, respectively, compared to those hav-
ing very little (< 0.20) resemblance. Successive increments in
group II membership carry risks of 2.67, 7.13, and 29.0. Suc-
cessive increments in group III membership carry risks of 4,
16,and64.Higherlevelsofriskarepredictedby,forexample,
0.5membershipineachofgroupsIIandIII.Hence,clinically
relevant and statistically signiﬁcant results were obtained.
Taking the Rotterdam cohort as a guide, incidence in-
creases from 0.3 per 1000 person-years at ages 55 to 65 years
to 4.4 per 1000 person-years at ages 85 years and older [27].
The incidence of symptoms of parkinsonism was similar for
menandwomen,butmenmoreoftenmetdiagnosticcriteria
(male-to-female ratio, 1.54; 95% CI, 0.95 to 2.51), hence, the
great care taken in this study to consider age at onset. Be-
cause men were more often exposed to pesticides compared
to women, sex, per se, was not used to determine the risk
groups.
Biological interpretation is not straightforward, yet the
results lend further credence to the believe that faulty combi-
nations of mitochondrial complex I subunits pose signiﬁcant
risk for age-related PD, presumably, by reduced ATP produc-
tionandincreasedproductionofreactiveoxygenspecies.The
results imply that certain persons are robust and others vul-
nerable to PD when exposed to pesticides. Measurement of
pesticide exposure information was structured, but imper-
fect: memory fades; duration beyond six months was not in-
vestigated. One feature of GoM, the identiﬁcation of extreme
types, minimizes this problem by ﬁltering a lack of ﬁdelity
in the data. To the extent that groups are misidentiﬁed, risk
estimates would be expected to be biased toward the null,E. H. Corder and G. D. Mellick 7
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Denotes statistical signiﬁcance: the 95% CI for the odds
ratio does not include the neutral value of one.
(d)
Figure 2: The odds of PD were estimated for each age group (< age 60, 60 to 69, 70+) in logistic models. The predictors were membership
scores in the vulnerable groups II, III, and IV. The scores were coded categorically from 1 to 5 representing 0.20 increments. Risk multiplies
for each increment of 0.20. For example, at ages < 60, successive increments in group III membership carry risks of 4 (0.20–0.39), 16 (0.40
to 0.59), and 64 (0.60 to 0.79).
that is, underestimate risk. The ability of GoM to interpret
mixtures of genetic, clinical, and pathologic data is further
demonstrated in these referenced papers [28–34].
In summary, fuzzy latent class analysis was employed to
identify sets of polymorphisms located in nuclear genes en-
codingmitochondrialcomplexIproteinsassociatedwithPD,
and eﬀect modiﬁcation by toxin exposure. Even partial re-
semblance to the identiﬁed risk sets carried appreciable risk
for PD. This form of analysis may prove a particularly useful
way for hypothesis generation and subsequent investigation
of speciﬁc gene x gene and gene x environment interactions
in relation to common sporadic PD.
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